GE病人列表怎么删除Nrxp：LegacyWarrantsMember
6576678646917701000001719406财年错误NRX制药公司5881055066442989P2Y7M13DP8Y9M18DP0Y0M0DP0Y0M0DP0Y0M0DP3Y0001719406Nrxp：替代保修成员Nrxp:GemShareSubscriptionFacilityAgreementMember2021-07-012021-07-310001719406Nrxp：GEMWarrantMember2021-03-282021-03-280001719406Nrxp：投资者担保成员美国公认会计准则：次要事件成员2023-03-082023-03-080001719406Nrxp：首选投资选项成员2022-02-022022-02-020001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：订阅协议成员2022-01-012022-12-310001719406Nrxp：疫苗接种成员2021-10-152021-10-150001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：股票持有者神经成员2022-01-012022-12-310001719406Nrxp：股票持有者神经成员Nrxp：LegacyNeurorxPferredStockMember2021-05-242021-05-240001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMember2021-05-242021-05-240001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：股票持有者神经成员2021-05-232021-05-230001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMember2021-05-232021-05-230001719406美国-公认会计准则：保留预付款成员2022-12-310001719406US-GAAP：AdditionalPaidInCapitalMembers2022-12-310001719406美国-公认会计准则：保留预付款成员2021-12-310001719406US-GAAP：AdditionalPaidInCapitalMembers2021-12-310001719406美国-公认会计准则：保留预付款成员2020-12-310001719406US-GAAP：AdditionalPaidInCapitalMembers2020-12-310001719406美国-美国公认会计准则：普通股成员2022-12-310001719406美国-美国公认会计准则：普通股成员2021-12-310001719406美国-美国公认会计准则：普通股成员2020-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：订阅协议成员2022-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：股票持有者神经成员2021-05-240001719406Nrxp：虚拟股票选项成员美国-公认会计准则：研究和开发费用成员2021-01-012021-12-310001719406Nrxp：虚拟股票选项成员美国-公认会计准则：一般和行政费用成员2021-01-012021-12-310001719406Nrxp：虚拟股票选项成员2021-01-012021-12-310001719406美国-美国公认会计准则：普通股成员2022-01-012022-12-310001719406NRXP：两千六十六个大企业计划成员2022-12-310001719406Nrxp：两千两个OneOmnibus计划成员2022-01-012022-01-010001719406Nrxp：原始选项成员2022-01-012022-12-310001719406Nrxp：LegacyWarrantsMember2022-01-012022-12-310001719406SRT：最小成员数美国公认会计准则：选项成员2022-01-012022-12-310001719406SRT：最小成员数Nrxp：替代保修成员2022-01-012022-12-310001719406SRT：最小成员数Nrxp：替代选项成员2022-01-012022-12-310001719406SRT：最小成员数Nrxp：原始选项成员2022-01-012022-12-310001719406SRT：最小成员数Nrxp：LegacyWarrantsMember2022-01-012022-12-310001719406SRT：最大成员数美国公认会计准则：选项成员2022-01-012022-12-310001719406SRT：最大成员数Nrxp：替代选项成员2022-01-012022-12-310001719406SRT：最大成员数Nrxp：原始选项成员2022-01-012022-12-310001719406SRT：最大成员数Nrxp：LegacyWarrantsMember2022-01-012022-12-310001719406SRT：最小成员数美国公认会计准则：选项成员2021-01-012021-12-310001719406SRT：最大成员数美国公认会计准则：选项成员2021-01-012021-12-310001719406US-GAAP：PrivatePlacementMembers2022-02-022022-02-020001719406美国公认会计准则：选项成员2021-01-012021-12-310001719406SRT：最小成员数Nrxp：替代保修成员2022-12-310001719406SRT：最小成员数Nrxp：替代选项成员2022-12-310001719406SRT：最小成员数Nrxp：原始选项成员2022-12-310001719406SRT：最小成员数Nrxp：LegacyWarrantsMember2022-12-310001719406SRT：最大成员数Nrxp：替代保修成员2022-12-310001719406SRT：最大成员数Nrxp：替代选项成员2022-12-310001719406SRT：最大成员数Nrxp：原始选项成员2022-12-310001719406SRT：最大成员数Nrxp：LegacyWarrantsMember2022-12-310001719406Nrxp:RestrictionsRemovedOnNewDrugApprovalDateMember2023-03-292023-03-290001719406Nrxp:RestrictionsRemovedOnNewDrugApplicationDateMember2023-03-292023-03-290001719406美国-公认会计准则：受限的股票成员2022-07-122022-07-120001719406美国公认会计准则：选项成员2022-01-012022-12-310001719406Nrxp：替代选项成员2022-01-012022-12-310001719406US-GAAP：PrivatePlacementMembers2022-02-020001719406Nrxp：首选投资选项成员2022-02-020001719406Nrxp：PilltrackerSowMember2022-01-012022-12-310001719406Nrxp：GlytechAgreement成员2022-01-012022-12-310001719406Nrxp：FormerChiefExecutiveOfficerMember2022-01-012022-12-310001719406Nrxp：首席执行官执行官员SonMember2022-01-012022-12-310001719406SRT：最大成员数Nrxp：首席执行官执行官员SonMember2021-01-012021-12-310001719406Nrxp：PilltrackerSowMember2021-01-012021-12-310001719406Nrxp：GlytechAgreement成员2021-01-012021-12-310001719406Nrxp：FormerChiefExecutiveOfficerMember2021-01-012021-12-310001719406NRXP：ReliefTreeuticsLoanMembers2022-04-062022-04-0600017194062023-03-082023-03-080001719406US-GAAP：PrivatePlacementMembers2022-02-022022-02-020001719406Nrxp:ConvertibleSeriesBTwoPreferredStockMemberNrxp：LegacyNeurorxPferredStockMember2020-03-310001719406Nrxp：LegacyWarrantsMemberNrxp:ConvertibleSeriesBOnePreferredStockMember2022-12-310001719406Nrxp：LegacyWarrantsMemberNrxp:ConvertibleSeriesBOneAPreferredStockMember2022-12-310001719406Nrxp：LegacyWarrantsMemberNrxp：ConvertibleSeriesAPferredStockMember2022-12-310001719406Nrxp:ConvertibleSeriesBOnePreferredStockMember2022-12-310001719406Nrxp:ConvertibleSeriesBOneAPreferredStockMember2022-12-310001719406Nrxp：ConvertibleSeriesAPferredStockMember2022-12-310001719406Nrxp:ConvertibleSeriesBTwoPreferredStockMemberNrxp：LegacyNeurorxPferredStockMember2020-12-310001719406Nrxp：ConvertibleSeriesAPferredStockMemberNrxp：LegacyNeurorxPferredStockMember2022-01-012022-12-310001719406Nrxp:ConvertibleSeriesBTwoPreferredStockMemberNrxp：LegacyNeurorxPferredStockMember2020-01-012020-12-310001719406美国-公认会计准则：州和地方法律法规成员2022-12-310001719406美国-公认会计准则：外国成员2022-12-310001719406美国-GAAP：国内/地区成员2022-12-310001719406美国-公认会计准则：州和地方法律法规成员2021-12-310001719406美国-公认会计准则：外国成员2021-12-310001719406美国-GAAP：国内/地区成员2021-12-310001719406SRT：最大成员数2022-01-012022-12-310001719406SRT：最大成员数2021-01-012021-12-310001719406美国-公认会计准则：保留预付款成员2022-01-012022-12-310001719406美国-公认会计准则：保留预付款成员2021-01-012021-12-310001719406美国-公认会计准则：待决诉讼成员Nrxp:GemShareSubscriptionFacilityAgreementMember2022-08-122022-08-120001719406美国公认会计准则：保修成员2022-12-310001719406美国公认会计准则：保修成员2021-12-310001719406Nrxp：EarnoutCashLibiltiesMembers2021-12-310001719406美国公认会计准则：保修成员2021-01-012021-12-310001719406Nrxp：EarnoutCashLibiltiesMembers2021-01-012021-12-310001719406美国公认会计准则：保修成员2022-01-012022-12-310001719406Nrxp：EarnoutCashLibiltiesMembers2022-01-012022-12-310001719406美国-公认会计准则：受限的股票成员2022-12-310001719406美国-公认会计准则：受限的股票成员2022-01-012022-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：替代保修成员2021-05-240001719406SRT：最大成员数Nrxp：替代保修成员2022-01-012022-12-310001719406Nrxp：安置保修成员2022-01-012022-12-310001719406Nrxp：替代保修成员2021-01-012021-12-310001719406Nrxp：安置保修成员2021-01-012021-12-310001719406Nrxp：PromissoryNote9可赎回成员2022-11-042022-11-040001719406Nrxp：PromissoryNote9可赎回成员2022-11-040001719406NRXP：ReliefTreeuticsLoanMembers2020-04-060001719406Nrxp:ConvertibleSeriesBTwoPreferredStockMemberNrxp：LegacyNeurorxPferredStockMember2021-05-240001719406Nrxp：ConvertibleSeriesAPferredStockMemberNrxp：LegacyNeurorxPferredStockMember2021-05-240001719406美国-公认会计准则：公允价值投入级别3成员US-GAAP：可转换节点PayableMember2022-12-310001719406Nrxp:GemShareSubscriptionFacilityAgreementMember2022-12-310001719406Nrxp：安置保修成员2022-12-310001719406美国-美国公认会计准则：普通股成员美国公认会计准则：次要事件成员2023-03-080001719406美国公认会计准则：次要事件成员2023-03-080001719406Nrxp：公共保修成员2022-12-310001719406Nrxp：替代保修成员2021-12-310001719406美国-公认会计准则：公允价值输入级别1成员美国-GAAP：公允价值衡量递归成员2022-12-310001719406美国-公认会计准则：公允价值输入级别1成员美国-GAAP：公允价值衡量递归成员2021-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：股票持有者神经成员2021-05-242021-05-240001719406美国公认会计准则：保修成员2022-01-012022-12-310001719406美国-公认会计准则：受限的股票成员2022-01-012022-12-310001719406美国-公认会计准则：员工股票期权成员2022-01-012022-12-310001719406美国公认会计准则：保修成员2021-01-012021-12-310001719406美国-公认会计准则：员工股票期权成员2021-01-012021-12-310001719406Nrxp:EarnoutSharesFromExercisedSubstituteOptionsAndSubstituteWarrantsMember2021-01-012021-12-310001719406SRT：最大成员数美国-公认会计准则：受限的股票成员2022-01-012022-12-310001719406美国-公认会计准则：研究和开发费用成员2022-01-012022-12-310001719406美国-公认会计准则：一般和行政费用成员2022-01-012022-12-310001719406美国-公认会计准则：一般和行政费用成员美国-美国公认会计准则：普通股成员2021-01-012021-12-310001719406美国-公认会计准则：研究和开发费用成员2021-01-012021-12-310001719406SRT：最大成员数2022-12-310001719406Nrxp：GEMWarrantMemberNrxp:GemShareSubscriptionFacilityAgreementMember2021-03-282021-03-280001719406Nrxp：公共保修成员2021-01-012021-12-310001719406美国-公认会计准则：公允价值投入级别3成员美国-GAAP：公允价值衡量递归成员2022-01-012022-12-310001719406美国-公认会计准则：公允价值投入级别3成员美国-GAAP：公允价值衡量递归成员2021-01-012021-12-310001719406Nrxp：GEMWarrantMemberNrxp:GemShareSubscriptionFacilityAgreementMember2021-03-280001719406US-GAAP：PrivatePlacementMembers2022-02-020001719406美国公认会计准则：次要事件成员2023-03-082023-03-080001719406Nrxp：两千两个OneOmnibus计划成员2022-12-310001719406Nrxp:GemShareSubscriptionFacilityAgreementMember2021-03-282021-03-280001719406Nrxp：替代保修成员2022-01-012022-12-310001719406Nrxp：SponsoredResearchAgreement成员2022-12-3100017194062023-03-292023-03-290001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：替代保修成员2021-05-242021-05-240001719406NRXP：乔纳森·贾维特博士2023-03-292023-03-290001719406Nrxp：两千两个OneOmnibus计划成员2022-01-012022-12-310001719406美国-公认会计准则：一般和行政费用成员2021-01-012021-12-310001719406Nrxp：PromissoryNote9可赎回成员2022-12-310001719406美国-公认会计准则：公允价值投入级别3成员US-GAAP：可转换节点PayableMember2022-01-012022-12-310001719406Nrxp：PromissoryNote9可赎回成员2022-01-012022-12-310001719406美国-公认会计准则：公允价值投入级别3成员美国-GAAP：公允价值衡量递归成员2022-12-310001719406美国-公认会计准则：公允价值投入级别3成员美国-GAAP：公允价值衡量递归成员2021-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：股票持有者神经成员2021-01-012021-12-310001719406Nrxp：首选投资选项成员2022-02-022022-02-020001719406美国-美国公认会计准则：普通股成员2021-01-012021-12-310001719406Nrxp：EarnoutSharesMember2021-01-012021-12-310001719406美国-美国公认会计准则：普通股成员2022-01-012022-12-310001719406US-GAAP：AdditionalPaidInCapitalMembers2022-01-012022-12-310001719406美国-美国公认会计准则：普通股成员2021-01-012021-12-310001719406Nrxp:GemShareSubscriptionFacilityAgreementMember2022-01-012022-12-310001719406NRXP：ReliefTreeuticsHoldingsAgMemberSRT：最大成员数NRXP：ReliefTreeuticsLawsuitMemberNrxp:ReliefTherapeuticsCollaborationAgreementMember2020-09-180001719406NRXP：ReliefTreeuticsHoldingsAgMemberNRXP：ReliefTreeuticsLawsuitMemberNrxp:ReliefTherapeuticsCollaborationAgreementMember2020-09-180001719406SRT：场景先前报告的成员2020-01-012020-12-3100017194062020-01-012020-12-3100017194062020-12-310001719406Nrxp：公共保修成员2022-01-012022-12-310001719406Nrxp：首选投资选项成员2022-02-020001719406SRT：重新调整成员2020-12-310001719406SRT：场景先前报告的成员2020-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMember2021-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp：股票持有者神经成员2021-12-310001719406Nrxp：替代保修成员2021-05-240001719406Nrxp：替代选项成员2021-05-240001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMember2021-05-240001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMember2021-01-012021-12-310001719406Nrxp:MergerAgreementWithMergerSubAndNeurorxMemberNrxp:BigRockPartnersAcquisitionFounderAndPrivateShareholdersMember2021-01-012021-12-310001719406US-GAAP：AdditionalPaidInCapitalMembers2021-01-012021-12-3100017194062021-01-012021-12-310001719406Nrxp:GemShareSubscriptionFacilityAgreementMember2020-12-3100017194062021-12-310001719406美国公认会计准则：保修成员2022-01-012022-12-310001719406美国-美国公认会计准则：普通股成员2022-01-012022-12-3100017194062022-12-3100017194062023-03-2900017194062022-01-012022-12-31Xbrli：共享ISO 4217：美元ISO 4217：美元Xbrli：共享Nrxp：DXbrli：纯ISO 4217：港币